Medical ethics committee approves of anti-Covid drug Lagevrio
Slovenia’s national medical ethics committee has no reservations towards Lagevrio, a medicine also known as molnupiravir. The committee maintains that the drug brings significant progress in fighting the coronavirus epidemic, as it prevents a severe course of Covid-19 or death. The European Medicines Agency (EMA) recommended the drug for coronavirus treatment on 19 November even …
Medical ethics committee approves of anti-Covid drug Lagevrio Read More »